These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 16209383)
21. Understanding the magnitude of occupational exposure to human immunodeficiency virus (HIV) and uptake of HIV post-exposure prophylaxis among healthcare workers in a rural district in Tanzania. Mabwe P; Kessy AT; Semali I J Hosp Infect; 2017 Jul; 96(3):276-280. PubMed ID: 28274607 [TBL] [Abstract][Full Text] [Related]
22. Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia. Zachary D; Mwenge L; Muyoyeta M; Shanaube K; Schaap A; Bond V; Kosloff B; de Haas P; Ayles H BMC Infect Dis; 2012 Aug; 12():183. PubMed ID: 22871032 [TBL] [Abstract][Full Text] [Related]
23. Performance of OraQuick Advance Rapid HIV-1/2 Antibody Test for detection of antibodies in oral fluid and serum/plasma in HIV-1+ subjects carrying different HIV-1 subtypes and recombinant variants. Holguín A; Gutiérrez M; Portocarrero N; Rivas P; Baquero M J Clin Virol; 2009 Jun; 45(2):150-2. PubMed ID: 19451023 [TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus postexposure prophylaxis for occupational exposure in a medical school hospital in Thailand. Hiransuthikul N; Hiransuthikul P; Kanasuk Y J Hosp Infect; 2007 Dec; 67(4):344-9. PubMed ID: 18023920 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of a rapid test for the detection of antibodies to human immunodeficiency virus type 1 and 2 in the setting of multiple transmitted viral subtypes. Reynolds SJ; Ndongala LM; Luo CC; Mwandagalirwa K; Losoma AJ; Mwamba KJ; Bazepeyo E; Nzilambi NE; Quinn TC; Bollinger RC Int J STD AIDS; 2002 Mar; 13(3):171-3. PubMed ID: 11860693 [TBL] [Abstract][Full Text] [Related]
26. [HIV post exposure prophylaxis therapy - the experience of two major AIDS centers]. Elbirt D; Levy I; Asher I; Mahlev-Guri K; Rosenberg-Bezalet S; Litachevsky S; Radian-Sade S; Sthoeger Z Harefuah; 2013 Apr; 152(4):224-9, 246. PubMed ID: 23844525 [TBL] [Abstract][Full Text] [Related]
27. Blood and body fluid exposures in the French military. Dia A; Verret C; Pommier de Santi V; Tanti M; Decam C; Migliani R; Deparis X Occup Med (Lond); 2012 Mar; 62(2):141-4. PubMed ID: 22084311 [TBL] [Abstract][Full Text] [Related]
28. Spare post-exposure prophylaxis with round-the-clock HIV testing of the source patient. Greub G; Maziéro A; Bürgisser P; Telenti A; Francioli P AIDS; 2001 Dec; 15(18):2451-2. PubMed ID: 11774831 [TBL] [Abstract][Full Text] [Related]
29. Adolescent preferences for human immunodeficiency virus testing methods and impact of rapid tests on receipt of results. Kowalczyk Mullins TL; Braverman PK; Dorn LD; Kollar LM; Kahn JA J Adolesc Health; 2010 Feb; 46(2):162-8. PubMed ID: 20113922 [TBL] [Abstract][Full Text] [Related]
30. Performance of Determine Combo and other point-of-care HIV tests among Seattle MSM. Stekler JD; Ure G; O'Neal JD; Lane A; Swanson F; Maenza J; Stevens C; Coombs RW; Dragavon J; Swenson PD; Golden MR J Clin Virol; 2016 Mar; 76():8-13. PubMed ID: 26774543 [TBL] [Abstract][Full Text] [Related]
31. Incidence of visits for health care worker blood or body fluid exposures and HIV postexposure prophylaxis provision at Rhode Island emergency departments. Merchant RC; Chee KJ; Liu T; Mayer KH J Acquir Immune Defic Syndr; 2008 Mar; 47(3):358-68. PubMed ID: 18176321 [TBL] [Abstract][Full Text] [Related]
32. Pilot of non-invasive (oral fluid) testing for HIV within a clinical setting. Debattista J; Bryson G; Roudenko N; Dwyer J; Kelly M; Hogan P; Patten J Sex Health; 2007 Jun; 4(2):105-9. PubMed ID: 17524288 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group. Gallo D; George JR; Fitchen JH; Goldstein AS; Hindahl MS JAMA; 1997 Jan; 277(3):254-8. PubMed ID: 9005276 [TBL] [Abstract][Full Text] [Related]
34. High risk for occupational exposure to HIV and utilization of post-exposure prophylaxis in a teaching hospital in Pune, India. Gupta A; Anand S; Sastry J; Krisagar A; Basavaraj A; Bhat SM; Gupte N; Bollinger RC; Kakrani AL BMC Infect Dis; 2008 Oct; 8():142. PubMed ID: 18939992 [TBL] [Abstract][Full Text] [Related]
35. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention. MMWR Recomm Rep; 1998 May; 47(RR-7):1-33. PubMed ID: 9603630 [TBL] [Abstract][Full Text] [Related]
36. Occupational exposure to HIV infection in health care workers. Wnuk AM Med Sci Monit; 2003 May; 9(5):CR197-200. PubMed ID: 12761457 [TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Pinkerton SD; Holtgrave DR; Pinkerton HJ Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509 [TBL] [Abstract][Full Text] [Related]
38. Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe. Pascoe SJ; Langhaug LF; Mudzori J; Burke E; Hayes R; Cowan FM AIDS Patient Care STDS; 2009 Jul; 23(7):571-6. PubMed ID: 19530953 [TBL] [Abstract][Full Text] [Related]
39. Approval of a new rapid test for HIV antibody. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(46):1051-2. PubMed ID: 12487529 [TBL] [Abstract][Full Text] [Related]
40. Resource consumption in the infection control management of pertussis exposure among healthcare workers in pediatrics. Daskalaki I; Hennessey P; Hubler R; Long SS Infect Control Hosp Epidemiol; 2007 Apr; 28(4):412-7. PubMed ID: 17385146 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]